These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 1683146
1. Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines. Van Veldhuisen DJ, Crijns HJ, Girbes AR, Tobé TJ, Wiesfeld AC, Lie KI. Am J Cardiol; 1991 Nov 01; 68(11):1194-202. PubMed ID: 1683146 [Abstract] [Full Text] [Related]
2. Efficacy and safety of ibopamine in congestive heart failure. van Veldhuisen DJ, Girbes AR, Crijns HJ, Smit AJ, de Graeff PA, Lie KI. J Auton Pharmacol; 1990 Nov 01; 10 Suppl 1():s115-21. PubMed ID: 1983005 [Abstract] [Full Text] [Related]
3. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. G Ital Cardiol; 1989 Jan 01; 19(1):71-80. PubMed ID: 2663585 [Abstract] [Full Text] [Related]
4. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine. Metra M, Missale C, Spano PF, Cas LD. J Cardiovasc Pharmacol; 1995 May 01; 25(5):732-40. PubMed ID: 7630152 [Abstract] [Full Text] [Related]
7. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure. Munger MA, Nara AR, Pospisil RA, Stoddard GJ, Schleman M. Pharmacotherapy; 1993 May 01; 13(3):218-23. PubMed ID: 8100627 [Abstract] [Full Text] [Related]
8. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, Withagen AJ, Pasteuning WH, Brouwer J, Lie KI. J Am Coll Cardiol; 1993 Nov 15; 22(6):1564-73. PubMed ID: 7901256 [Abstract] [Full Text] [Related]
9. Haemodynamic evaluation of ibopamine in severe congestive heart failure. Reffo GC, Turrin M, Gabellini A, Forattini C. Eur J Clin Pharmacol; 1984 Nov 15; 26(1):19-22. PubMed ID: 6714289 [Abstract] [Full Text] [Related]
10. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure. Ghirardi P, Brusoni B, Mangiavacchi M, Bianco L, Col J, Metra M, Dei Cas L. Br J Clin Pharmacol; 1985 May 15; 19(5):613-8. PubMed ID: 4005102 [Abstract] [Full Text] [Related]
11. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias. Miles WM, Heger JJ, Minardo JD, Klein LS, Prystowsky EN, Zipes DP. Am Heart J; 1989 Jan 15; 117(1):112-21. PubMed ID: 2521415 [Abstract] [Full Text] [Related]
16. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure. Nakano T, Morimoto Y, Kakuta Y, Konishi T, Kodera T, Kanamaru M, Takezawa H. Arzneimittelforschung; 1986 Dec 15; 36(12):1829-34. PubMed ID: 3551968 [Abstract] [Full Text] [Related]
17. The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure. Leier CV, Ren JH, Huss P, Unverferth DV. Pharmacotherapy; 1986 Dec 15; 6(1):35-40. PubMed ID: 3952005 [Abstract] [Full Text] [Related]
19. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure. Gavazzi A, Mussini A, Bramucci E. Arzneimittelforschung; 1986 Feb 15; 36(2A):366-70. PubMed ID: 3707652 [Abstract] [Full Text] [Related]
20. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure. Naccarelli GV, Gray EL, Dougherty AH, Hanna JE, Goldstein RA. Am J Cardiol; 1984 Sep 01; 54(6):600-4. PubMed ID: 6475780 [Abstract] [Full Text] [Related] Page: [Next] [New Search]